Troponin I, and Lactic Acid variations, during Cardiopulmonary Bypass under Moderate Hypothermia vs Normothermia.
Zeka M et al. - Troponin I, and Lactic Acid variations, during Cardiopulmonary Bypass under Moderate Hypothermia vs Normothermia.


Cardiopulmonary Bypass
Moderate Hypothermia
Cardiac Surgery
Coronary artery Bypass Grafting
Troponin I
Lactic Acid

How to Cite

Zeka, M., Kuci, S., Arapi, B., Ibrahimi, A., & Lilaj, K. (2023). Troponin I, and Lactic Acid variations, during Cardiopulmonary Bypass under Moderate Hypothermia vs Normothermia. Albanian Journal of Trauma and Emergency Surgery, 7(1), 1125-1129.


Introduction: In open heart surgery such as Coronary artery Bypass Grafting, valve repair or replacement, or some congenital heart disease, patients are connected to the Cardiopulmonary bypass machine [1]. Cardiopulmonary bypass machine pumps the blood around the body while the heart is stopped and provides a bloodless field during cardiac surgery. Since an extracorporeal circuit is incorporated to the patient, there are observed abnormal physiological events during Cardiopulmonary bypass. These events include hemodilution, interstitial fluid accumulation, complement activation and depression of immune system. Cardiopulmonary bypass is associated with an acute phase reaction of protease cascades, leucocyte, and platelet activation that result in tissue injury [2, 3] and limited functional reserve. For many years was believed that Cardiopulmonary bypass under hypothermia is much safer.  The main reason for “cooling body” is to protect the brain, heart and organs during cardiopulmonary bypass through reducing body metabolic rate [4]. During more recent years, according to many studies, it is shown that Cardiopulmonary bypass under Normothermia has much more advantages compared to Moderate Hypothermia.

The aim of this study was to compare and examine which method has advantages in terms of clinical outcome, morbidity and mortality.

Patients and methods. 60 patients were selected, who were scheduled for Coronary artery Bypass Grafting x 3, were enrolled in this study.

Results: According to the primary variables (Troponin I, Lactic Acid) and also secondary variables of our study, resulted that Cardiopulmonary bypass in Normothermia has superiority compare to Moderate Hypothermia in patients that underwent Coronary artery Bypass Grafting.

Conclusion: According to our data and literature [15, 16, 17], we concluded that Cardiopulmonary bypass in Coronary artery Bypass Grafting under Normothermia has advantages vs Moderate Hypothermia and Troponin I and Lactic Acid are very good biomarkers that show us if heart and organs perfusion/protection is adequate during this procedure.
Zeka M et al. - Troponin I, and Lactic Acid variations, during Cardiopulmonary Bypass under Moderate Hypothermia vs Normothermia.


Gravlee GP, Davis RF, Kurusz M, Utley JR, editors. Historical Development of Cardiopulmonary Bypass: Cardiopulmonary Bypass Principles and Practice. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 5

Eggum R, Ueland T, Mollnes TE, Videm V, Aukrust P, Fiane AE, et al. Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery. Ann Thorac Surg. 2008; 85:611–7.

Stocker CF, Shekerdemian LS, Horton SB, Lee KJ, Eyres R, D’Udekem Y, et al. The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: A randomized trial. J Thorac Cardiovasc Surg. 2011; 142:174–80.

Wang CH, Chen NC, Tsai MS, Yu PH, Wang AY, Chang WT, et al. Therapeutic hypothermia and the risk of hemorrhage: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2015; 94: e2152. [PMC free article] [PubMed] [Google Scholar]

Xiong Y, Sun Y, Ji B, Liu J, Wang G, Zheng Z, et al. Systematic review and meta-analysis of benefits and risks between normothermia and hypothermia during cardiopulmonary bypass in pediatric cardiac surgery. Paediatr Anaesth. 2015; 25:135–42.

Januzzi JL, Lewandrowski K, MacGillivray TE. et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002; 39:1518–1523.

Cosgrave J, Foley B, Ho E. et al. Troponin T elevation after coronary bypass surgery: clinical relevance and correlation with perioperative variables. J Cardiovasc Med (Hagerstown) 2006; 7:669–674

Mohammed AA, Agnihotri AK, van Kimmenade RR. et al. Prospective, Comprehensive Assessment of Cardiac Troponin T Testing Following Coronary Artery Bypass Graft Surgery. Circulation. 2009

Nesher N, Alghamdi AA, ingh SK, Sever JY, Christakis GT, Goldman BS, Cohen GN, Moussa F, Fremes SE. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg. 2008 Apr;85(4):1348-54. doi: 10.1016/j.athoracsur.2007.12.077. PMID: 18355525

Munoz R, Laussen PC, Palacio G, Zienko L, Piercey G, Wessel DL, et al. Changes in whole blood lactate levels during cardiopulmonary bypass for surgery for congenital cardiac disease: An early indicator of morbidity and mortality. J Thorac Cardiovasc Surg. 2000; 119:155–62.

Onorati F, De Feo M, Mastroroberto P, Cristodoro L, Pezzo F, Renzulli A, Cotrufo M. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg. 2005 Mar;79(3):837-45. doi: 10.1016/j.athoracsur.2004.07.060. PMID: 15734390 J Thorac Cardiovasc Surg. 2008 May;135(5):1110-9, 1119.e1-10. doi: 10.1016/j.jtcvs.2007.12.029.

Dong MF, Ma ZS, Wang JT, Chai SD, Tang PZ, Wang LX. Impact of peripherally established cardiopulmonary bypass on regional and systemic blood lactate levels. Heart Lung Circ. 2012 Mar;21(3):154-8. doi: 10.1016/j.hlc.2011.10.014. Epub 2011 Nov 29. PMID: 22129493

Noval-Padillo JA, Serra-Gomez C, Gomez-Sosa L, Hinojosa-Perez R, Huici-Moreno MJ, Adsuar A, Herruzo-Avilés A, Lopez-Romero JL, León-Justel A, Guerrero-Montavez JM. Changes of lactate levels during cardiopulmonary bypass in patients undergoing cardiac transplantation: possible early marker of morbidity and mortality. Transplant Proc. 2011 Jul-Aug;43(6):2249-50. doi: 10.1016/j.transproceed. 2011.06.046. PMID: 21839247

Calafiore AM, Teodori G, Mezzetti A, Bosco G, Verna AM, Di Giammarco G et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59:398–402

Johansson BW. The hibernator heart—nature's model of resistance to ventricular fibrillation. Cardiovasc Res. 1996; 31:826–832.

Huh PW, Belayev L, Zhao W, Koch S, Busto R, Ginsberg MD. Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia. J Neurosurg. 2000; 92:91–99.

Liu L, Yenari MA. Therapeutic hypothermia: neuroprotective mechanisms. Front Biosci. 2007; 12:816–825

Slikker W, 3rd, Desai VG, Duhart H, Feuers R, Imam SZ. Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. Free Radic Biol Med. 2001; 31:405–411.

Dae MW, Gao DW, Sessler DI, Chair K, Stillson CA. Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol Heart Circ Physiol. 2002;282:H1584–H1591.

Shamsuddin AM, Nikman AM, Ali S, Zain MR, Wong AR, Corno AF, et al. Normothermia

for pediatric and congenital heart surgery: An expanded horizon. Front Pediatr. 2015; 3:23.

Pouard P, Mauriat P, Ek F, Haydar A, Gioanni S, Laquay N, et al. Normothermic cardiopulmonary bypass and myocardial cardioplegic protection for neonatal arterial switch operation. Eur J Cardiothorac Surg. 2006; 30:695–9.

Cassano V,Milella L.Warm surgery: Our experience. Eur J Cardiothorac Surg. 2007; 31:754– 5.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.